Lynn Slobbe

688 total citations
26 papers, 562 citations indexed

About

Lynn Slobbe is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Lynn Slobbe has authored 26 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 8 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Lynn Slobbe's work include Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (8 papers) and Immune Response and Inflammation (7 papers). Lynn Slobbe is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (8 papers) and Immune Response and Inflammation (7 papers). Lynn Slobbe collaborates with scholars based in New Zealand, United States and Australia. Lynn Slobbe's co-authors include G.S. Buchan, Glenn Buchan, J.F.T. Griffin, Euan Lockhart, Bryce M. Buddle, A.J. Thomson, C.G. Mackintosh, Sarah L. Young, Michael R. Eccles and Margaret A. Baird and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Journal of Nutrition.

In The Last Decade

Lynn Slobbe

26 papers receiving 552 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lynn Slobbe New Zealand 15 305 243 208 188 71 26 562
Caitlyn R. Scharn United States 6 269 0.9× 285 1.2× 249 1.2× 269 1.4× 31 0.4× 8 620
Reta S. Gibbons United States 15 286 0.9× 369 1.5× 482 2.3× 188 1.0× 78 1.1× 20 858
Katrina B. Mar United States 9 223 0.7× 189 0.8× 120 0.6× 208 1.1× 43 0.6× 14 517
Ibrahim Al-Mohsen United States 10 448 1.5× 244 1.0× 363 1.7× 110 0.6× 145 2.0× 14 834
Andrew Montemarano United States 13 189 0.6× 110 0.5× 123 0.6× 103 0.5× 47 0.7× 16 615
Juliane Lippmann Germany 10 380 1.2× 344 1.4× 334 1.6× 289 1.5× 34 0.5× 11 805
Megumi Okuyama Japan 10 367 1.2× 181 0.7× 457 2.2× 329 1.8× 30 0.4× 12 1.0k
Som G. Nanjappa United States 13 316 1.0× 229 0.9× 194 0.9× 103 0.5× 111 1.6× 25 589
Françoise Sanchez France 12 408 1.3× 144 0.6× 225 1.1× 164 0.9× 61 0.9× 14 728
Shiping Wu China 12 317 1.0× 270 1.1× 241 1.2× 161 0.9× 58 0.8× 27 712

Countries citing papers authored by Lynn Slobbe

Since Specialization
Citations

This map shows the geographic impact of Lynn Slobbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn Slobbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn Slobbe more than expected).

Fields of papers citing papers by Lynn Slobbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn Slobbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn Slobbe. The network helps show where Lynn Slobbe may publish in the future.

Co-authorship network of co-authors of Lynn Slobbe

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn Slobbe. A scholar is included among the top collaborators of Lynn Slobbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn Slobbe. Lynn Slobbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eccles, Michael R., Shujie He, Antonio Ahn, et al.. (2013). MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a “Genetic Switch” Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma. Frontiers in Oncology. 3. 229–229. 28 indexed citations
2.
3.
He, Shujie, et al.. (2010). PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression. Melanoma Research. 21(1). 24–34. 18 indexed citations
4.
Young, Sarah L., Lynn Slobbe, Matthew Peacey, et al.. (2010). Immunogenicity and protective efficacy of mycobacterial DNA vaccines incorporating plasmid‐encoded cytokines against Mycobacterium bovis. Immunology and Cell Biology. 88(6). 651–657. 4 indexed citations
5.
Jeffs, Aaron, Lynn Slobbe, Li Wang, et al.. (2009). A Gene Expression Signature of Invasive Potential in Metastatic Melanoma Cells. PLoS ONE. 4(12). e8461–e8461. 67 indexed citations
6.
Williman, Jonathan, Sarah L. Young, G.S. Buchan, et al.. (2008). DNA fusion vaccines incorporating IL-23 or RANTES for use in immunization against influenza. Vaccine. 26(40). 5153–5158. 15 indexed citations
7.
Davies, Corinne S., Michelle McConnell, Lynn Slobbe, Neill W. Haggarty, & Glenn Buchan. (2005). Murine Antigen-Presenting Cells Are Multifunctional In Vitro Biosensors for Detecting the Immunoactive Potential of Bovine Milk Products. Journal of Nutrition. 135(11). 2651–2656. 5 indexed citations
8.
Williman, Jonathan, Euan Lockhart, Lynn Slobbe, Glenn Buchan, & Margaret A. Baird. (2005). The use of Th1 cytokines, IL-12 and IL-23, to modulate the immune response raised to a DNA vaccine delivered by gene gun. Vaccine. 24(21). 4471–4474. 22 indexed citations
9.
Baird, Margaret A., Rachel Wilson, Louise J. Young, et al.. (2004). Bystander Help within a Polyepitope DNA Vaccine Improves Immune Responses to Influenza Antigens. Scandinavian Journal of Immunology. 60(4). 363–371. 11 indexed citations
10.
Faulkner, L, G.S. Buchan, Lynn Slobbe, et al.. (2003). Influenza hemagglutinin peptides fused to interferon gamma and encapsulated in liposomes protects mice against influenza infection. Vaccine. 21(9-10). 932–939. 17 indexed citations
12.
Faulkner, Lee, Glenn Buchan, Euan Lockhart, et al.. (2001). IL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells. International Immunology. 13(6). 713–721. 20 indexed citations
13.
Aldwell, Frank E., D. Neil Wedlock, Lynn Slobbe, et al.. (2001). In vitro control of Mycobacterium bovis by macrophages. Tuberculosis. 81(1-2). 115–123. 24 indexed citations
14.
Slobbe, Lynn, et al.. (2000). THE PRODUCTION AND BIOLOGICAL ASSESSMENT OF CERVINE INTERFERON GAMMA. Cytokine. 12(8). 1211–1217. 20 indexed citations
15.
Buchan, G.S., Sarah L. Young, Euan Lockhart, et al.. (2000). Targeting early events in T cell activation to construct improved vaccines. Molecular Immunology. 37(9). 545–552. 5 indexed citations
16.
Lockhart, Euan, Lynn Slobbe, & Glenn Buchan. (1999). The Characterisation of a Cervine Immunoregulatory Cytokine, Interleukm 12. DNA sequence. 10(2). 139–148. 2 indexed citations
17.
Griffin, J.F.T., C.G. Mackintosh, Lynn Slobbe, A.J. Thomson, & G.S. Buchan. (1999). Vaccine protocols to optimise the protective efficacy of BCG. Tubercle and Lung Disease. 79(3). 135–143. 96 indexed citations
18.
Cross, Martin L., A.J. Thomson, Lynn Slobbe, J.F.T. Griffin, & G.S. Buchan. (1996). Macrophage function in deer. Veterinary Immunology and Immunopathology. 49(4). 359–373. 16 indexed citations
19.
Cross, Martin L., Lynn Slobbe, G.S. Buchan, & J.F.T. Griffin. (1996). In vitro responses of cervine macrophages to bacterial stimulants. Veterinary Immunology and Immunopathology. 53(3-4). 249–256. 4 indexed citations
20.
Lockhart, Euan, Lynn Slobbe, Louis Droogmans, Frank Griffin, & Glenn Buchan. (1995). The cloning and sequencing of cervine interleukin 10. DNA sequence. 5(5). 265–268. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026